We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Atlantic Union Bankshares
AUB
$6.09B
| $769K | ﹤0.01% |
20,416
+4,100
| +25% | +$154K |
|
1052
Urban Edge Properties
UE
$2.78B
| $766K | ﹤0.01% |
35,790
+4,000
| +13% | +$80.5K |
|
1053
ManpowerGroup
MAN
$2.75B
| $765K | ﹤0.01% |
10,400
| – | – |
|
|
ROIC
1054
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $764K | ﹤0.01% |
48,597
+4,400
| +10% | +$64.3K |
|
|
PRFT
1055
DELISTED
Perficient Inc
PRFT
| $763K | ﹤0.01% |
10,112
+3,000
| +42% | +$226K |
|
1056
iRhythm Holdings
IRTC
$4.06B
| $760K | ﹤0.01% |
10,239
+2,600
| +34% | +$207K |
|
1057
LGI Homes
LGIH
$1.37B
| $754K | ﹤0.01% |
6,365
| – | – |
|
1058
Uranium Energy
UEC
$5.54B
| $753K | ﹤0.01% |
121,200
| – | – |
|
1059
Green Brick Partners
GRBK
$3.04B
| $752K | ﹤0.01% |
9,000
| – | – |
|
1060
Valley National Bancorp
VLY
$8.3B
| $752K | ﹤0.01% |
83,087
| – | – |
|
1061
Copa Holdings
CPA
$6.17B
| $751K | ﹤0.01% |
8,000
| – | – |
|
|
SWTX
1062
DELISTED
SpringWorks Therapeutics
SWTX
| $750K | ﹤0.01% |
23,400
+3,600
| +18% | +$135K |
|
1063
Calix
CALX
$2.51B
| $749K | ﹤0.01% |
19,300
+4,500
| +30% | +$165K |
|
1064
Carter's
CRI
$1.44B
| $749K | ﹤0.01% |
11,530
+5,500
| +91% | +$353K |
|
1065
First Hawaiian
FHB
$3.39B
| $748K | ﹤0.01% |
32,309
| – | – |
|
1066
Myriad Genetics
MYGN
$303M
| $747K | ﹤0.01% |
27,288
+3,100
| +13% | +$83.9K |
|
1067
Dutch Bros
BROS
$8.93B
| $746K | ﹤0.01% |
23,300
-4,900
| -17% | -$173K |
|
1068
Enpro
NPO
$7.12B
| $746K | ﹤0.01% |
4,600
+400
| +10% | +$62.3K |
|
1069
Outfront Media
OUT
$5.24B
| $746K | ﹤0.01% |
41,231
| – | – |
|
1070
Spectrum Brands
SPB
$2.09B
| $746K | ﹤0.01% |
7,843
| – | – |
|
1071
Federated Hermes
FHI
$4.74B
| $745K | ﹤0.01% |
20,253
+2,300
| +13% | +$78.8K |
|
|
EQC
1072
DELISTED
Equity Commonwealth
EQC
| $742K | ﹤0.01% |
37,303
+13,800
| +59% | +$275K |
|
1073
IDEAYA Biosciences
IDYA
$3.53B
| $741K | ﹤0.01% |
23,400
| – | – |
|
1074
Credo Technology Group
CRDO
$49.6B
| $739K | ﹤0.01% |
24,000
| – | – |
|
1075
Acadia Pharmaceuticals
ACAD
$4.89B
| $733K | ﹤0.01% |
47,633
+6,800
| +17% | +$113K |
|
Similar funds
GAM
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.